Table 2 Percentage of patients who saw reduction in CRP or tumour marker levels after IVC therapy “ ± ” indicates 95% confidence intervals, “†” indicates proportions significantly above 50%
From: Effect of high-dose intravenous vitamin C on inflammation in cancer patients
Cancer Type | N | % Improvement | |
|---|---|---|---|
CRP Reduction | |||
Prostate | 14 | 79 ± 21 | † |
Breast | 10 | 80 ± 25 | † |
All patients | 45 | 76 ± 13 | † |
Tumour Marker Reduction | |||
Prostate | 18 | 77 ± 21 | † |
All PSA | 20 | 75 ± 19 | † |
Breast | 11 | 73 ± 26 | |
All CA/CEA | 19 | 53 ± 22 | |
All patients | 40 | 65 ± 15 | † |